Unlike known receptor tyrosine kinases and cellular oncogenes, the use of a novel viral oncogene has the potential to uncover new and previously unexplored mechanisms involved in the initiation and progression of lung cancer. This evidence concerns the gene NTRK1 and lung cancer.